Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Tobira Therapeutics
company
About
Tobira Therapeutics is engaged in research and development of compounds for treating life-threatening and life-altering infectious diseases.
- 1 - 10
Highlights
Details
- Last Funding Type
- Convertable Note
- Last Funding Money Raised
- $13M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2006
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Tobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of life-threatening and life-altering infectious diseases. It develops TBR-652 and TBR-220 antagonists for the treatment of HIV/AIDS, hepatitis, and other associated infectious conditions. The company was founded in 2006 and is based in Princeton, New Jersey.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$13M
Tobira Therapeutics has raised a total of
$13M
in funding over 2 rounds. Their latest funding was raised on
Mar 9, 2015 from a Convertable Note round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 9, 2015 | Convertable Note | $13M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Tobira Therapeutics is funded by 1 investors.
Stonepine Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Convertable Note |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
